Janssen Gives Next-Gen CAR-Ts Another Shot After Fate Deal’s Collapse

J&J Inks New $245m Partnership With Cellular Biomedicine

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.